Major Ivermectin Study Omitted Hundreds of Participants, Researchers Say
By Zachary Stieber A large study examining ivermectin against COVID-19 included more participants than was reported in 2023, researchers acknowledged in a new correction. A U.S. government-funded trial arm examining ivermectin was said to have included 1,206 participants, including 602 who received ivermectin. The actual number of participants was 1,432, with 708 receiving ivermectin, Dr.
More Stories
Insider Selling: Harvey Norman Holdings Limited (ASX:HVN) Insider Sells 2,514 Shares of Stock
Harvey Norman Holdings Limited (ASX:HVN – Get Free Report) insider Kay Page sold 2,514 shares of the company’s stock in...
Roth Mkm Cuts MGP Ingredients (NASDAQ:MGPI) Price Target to $60.00
MGP Ingredients (NASDAQ:MGPI – Get Free Report) had its target price decreased by Roth Mkm from $65.00 to $60.00 in...
Helius Medical Technologies, Inc. Announces First PoNS System Sale to VA Healthcare SystemOn December 23, 2024, Helius Medical Technologies, Inc. (NASDAQ:HSDT) disclosed its successful sale of the first Portable Neuromodulation Stimulator (PoNS) Syst
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Traders Buy High Volume of Recursion Pharmaceuticals Call Options (NASDAQ:RXRX)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) saw some unusual options trading on Monday. Stock traders bought 13,040 call...
Microvast (NASDAQ:MVST) Shares Gap Up – What’s Next?
Microvast Holdings, Inc. (NASDAQ:MVST – Get Free Report) gapped up prior to trading on Monday . The stock had previously...
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL) Shares Gap Up – Time to Buy?
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL – Get Free Report)’s share price gapped up prior to trading on Monday...